Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma

Due to the lack of effective diagnostic markers and therapeutic targets, esophageal squamous cell carcinoma (ESCC) shows a poor 5 years survival rate of less than 30%. To explore the potential therapeutic targets of ESCC, we integrated and reanalyzed the mutation data of WGS (whole genome sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Binbin, Guo, Dinghe, Kong, Pengzhou, Wang, Yanqiang, Cheng, Xiaolong, Cui, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814608/
https://www.ncbi.nlm.nih.gov/pubmed/35127817
http://dx.doi.org/10.3389/fmolb.2021.792779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814608/
https://www.ncbi.nlm.nih.gov/pubmed/35127817
http://dx.doi.org/10.3389/fmolb.2021.792779

Ejemplares similares